Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Penumbra Inhibitors

The chemical class of Penumbra Inhibitors is designed to modulate the activities of Penumbra, a multifunctional protein also known as Tetraspanin-33. This protein plays an essential role in erythropoiesis, the production of red blood cells, and the differentiation of erythroid progenitors. Additionally, Penumbra regulates the activity and trafficking of the transmembrane metalloprotease ADAM10. This regulation is particularly crucial as ADAM10 is implicated in a variety of cellular processes, including cell adhesion and migration. Furthermore, Penumbra negatively regulates ligand-induced Notch activity, likely through its modulation of ADAM10. The protein also mediates the docking of ADAM10 to zonula adherens, interacting with ADAM10 and the zonula adherens protein PLEKHA7 in a PDZD11-dependent manner. Given these multiple roles, inhibitors in this class could be designed to target specific interactions or regulatory functions carried out by Penumbra.

Understanding the mechanisms of action for inhibitors in this class requires intricate knowledge of cellular biochemistry and signaling pathways, especially those relevant to erythroid cell differentiation, metalloprotease activity, and Notch signaling. Some inhibitors, such as those targeting ADAM10, aim to directly influence the enzymatic activities that Penumbra regulates. Others might focus on pathways that Penumbra indirectly affects, like Notch signaling inhibitors, which could alter Penumbra's role in cellular differentiation and signaling balance. The inhibitors in this class are thus highly specialized, tailored to affect the various cellular processes and interactions where Penumbra plays a key role, making it a complex but fascinating area of biochemical research.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GI 254023X

260264-93-5sc-490114
1 mg
$163.00
1
(0)

GI 254023X is an ADAM10 inhibitor and could directly affect Penumbra's role in regulating ADAM10 activity, thereby potentially influencing erythroid differentiation.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$99.00
$335.00
$836.00
$2099.00
47
(3)

DAPT is a Notch signaling pathway inhibitor that could indirectly affect Penumbra's role in regulating Notch activity, given its negative regulation of Notch.

LY411575

209984-57-6sc-364529
sc-364529A
10 mg
50 mg
$194.00
$464.00
6
(1)

LY411575 is another Notch inhibitor that could affect Penumbra's role in negatively regulating Notch activity, which in turn might impact erythroid differentiation.

TAPI-1

171235-71-5sc-222337
1 mg
$656.00
15
(1)

TAPI-1 inhibits ADAM17, which is a metalloprotease like ADAM10. This could potentially influence Penumbra's role in regulating ADAM10.

BMS-906024

1401066-79-2sc-507372
10 mg
$3600.00
(0)

BMS-906024 inhibits Notch signaling and might influence Penumbra's regulatory role in this pathway, particularly its effect on erythroid differentiation.